不同雾化器在COPD急性加重期的临床疗效观察

Observation of the effect of different nebuliser on acute exacerbation of chronic obstructive pulmonary

目的观察不同雾化器在COPD急性加重期的疗效。方法42例COPD病急性加重期患者随机分为两组,分别使用喷射雾化器吸入博利康尼溶液和手压式定量雾化器吸入博利康尼气雾剂治疗,24小时后观察患者的病情变化。结果使用喷射雾化器吸入博利康尼溶液具有更好的疗效、较少的副作用。结论COPD急性加重期应重视喷射雾化器的运用。

Objective To observe the effect of different nebuliser on acute exacerbation of chronic obstructive pulmonary diseases （AECOPD）. Methods 42 cases were collected and randomized into two groups： one inhaled bricanyl solution and bricansol by nebuliser and the other had metered-dose inhaler （MDI）. Changes of the patients＇ condition were inspected after 24 hours. Results lnhaing bricanyl solution by nebuliser had better reaction and less adverse effect than by MDI. Conclusion Inhaling by nebuliser should be given more attention on AECOPD.